Global cord blood corporation announces results of 2021 annual general meeting

Hong kong, dec. 7, 2021 /prnewswire/ -- global cord blood corporation (nyse: co) ("gcbc" or the "company"), china's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2021 annual general meeting of shareholders, held on december 7, 2021, in hong kong s.a.r., china. at the annual general meeting, the company's shareholders ratified the re-appointment of kpmg huazhen llp as independent auditors of the company for the financial year ending march 31, 2022, and authorized any duly formed committee of the directors to fix the remuneration of the independent auditors; and re-elected ms.
CO Ratings Summary
CO Quant Ranking